Literature DB >> 9295331

Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme.

G Spizz1, P J Blackshear.   

Abstract

The importance of regulating the cellular concentrations of the myristoylated alanine-rich C kinase substrate (MARCKS), a major cellular substrate of protein kinase C, is indicated by the fact that mice lacking MARCKS exhibit gross abnormalities of central nervous system development and die shortly after birth. We previously identified a novel means of regulating cellular MARCKS concentrations that involved a specific proteolytic cleavage of the protein and implicated a cysteine protease in this process (Spizz, G., and Blackshear, P. J. (1996) J. Biol. Chem. 271, 553-562). Here we show that p40, the carboxyl-terminal fragment resulting from this cleavage of MARCKS, was associated with the mitochondrial/lysosomal pellet fraction of human diploid fibroblasts and that its generation in cells was sensitive to treatment with NH4Cl. These data suggest the involvement of lysosomes in the generation and/or stability of p40. The MARCKS-cleaving enzyme (MCE) activity was peripherally associated with a 10,000 x g pellet fraction from bovine liver, and it co-purified with the activity and immunoreactivity of a lysosomal protease, cathepsin B. Cathepsin B catalyzed the generation of p40 from MARCKS in a cell-free system and behaved similarly to the MCE with respect to mutants of MARCKS previously shown to be poor substrates for the MCE. Treatment of fibroblasts with a cell-permeable, specific inhibitor of cathepsin B, CA074-Me, resulted in parallel time- and concentration-dependent inhibition of cathepsin B and MCE activity. Incubation of a synthetic MARCKS phosphorylation site domain peptide with purified cathepsin B resulted in cleavage of the peptide at sites consistent with preferred cathepsin B substrate sites. These data provide evidence for the identity of the MCE as cathepsin B and suggest that this cleavage most likely takes place within lysosomes, perhaps as a result of specific lysosomal targeting sequences within the MARCKS primary sequence. The data also suggest a direct interaction between MARCKS and cathepsin B in cells and leave open the possibility that MARCKS may in some way regulate the protease for which it is a substrate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295331     DOI: 10.1074/jbc.272.38.23833

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Cross-talk unfolded: MARCKS proteins.

Authors:  Anna Arbuzova; Arndt A P Schmitz; Guy Vergères
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.

Authors:  J V Peppard; A K Knap
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

3.  Myristoylated alanine-rich C kinase substrate-like protein-1 regulates epithelial sodium channel activity in renal distal convoluted tubule cells.

Authors:  Chang Song; Qiang Yue; Auriel Moseley; Otor Al-Khalili; Brandi M Wynne; Heping Ma; Lihua Wang; Douglas C Eaton
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

4.  Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.

Authors:  Michael C Yoon; Angelo Solania; Zhenze Jiang; Mitchell P Christy; Sonia Podvin; Charles Mosier; Christopher B Lietz; Gen Ito; William H Gerwick; Dennis W Wolan; Gregory Hook; Anthony J O'Donoghue; Vivian Hook
Journal:  ACS Chem Biol       Date:  2021-08-20       Impact factor: 4.634

5.  Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide.

Authors:  Elaine A Gay; Rebecca C Klein; Mark A Melton; Perry J Blackshear; Jerrel L Yakel
Journal:  J Pharmacol Exp Ther       Date:  2008-09-23       Impact factor: 4.030

Review 6.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

7.  Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage.

Authors:  Sandrine Dulong; Sebastien Goudenege; Karine Vuillier-Devillers; Stéphane Manenti; Sylvie Poussard; Patrick Cottin
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

8.  Transgenic Mice Overexpressing Human Alpha-1 Antitrypsin Exhibit Low Blood Pressure and Altered Epithelial Transport Mechanisms in the Inactive and Active Cycles.

Authors:  Lauren P Liu; Mohammed F Gholam; Ahmed Samir Elshikha; Tamim Kawakibi; Nasseem Elmoujahid; Hassan H Moussa; Sihong Song; Abdel A Alli
Journal:  Front Physiol       Date:  2021-09-22       Impact factor: 4.566

9.  Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range.

Authors:  Michael C Yoon; Vivian Hook; Anthony J O'Donoghue
Journal:  Biochemistry       Date:  2022-08-18       Impact factor: 3.321

Review 10.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.